Therapeutic Areas: Gastroenterology

Choose Therapeutic Area
Infectious diseases incl. Covid-19
Rare diseases
Cromos Pharma provides clinical trial management services for drug and medical device development in the field of gastroenterology

We offer a wide range of services, including study design, site selection and management, patient recruitment, data management, medical writing, and regulatory submissions. Cromos Pharma has expertise in the complex regulatory and ethical issues involved in gastroenterology research, including the use of endoscopic procedures, patient safety, and informed consent.

We have vast experience in the conduct of clinical trials for inflammatory bowel disease (IBD), including both Crohn’s disease and Ulcerative Colitis. Cromos Pharma has a strong track record of designing and managing clinical trials to evaluate the safety and efficacy of new IBD treatments, including biologics and small molecules.

We also have experience in evaluating treatments for liver disease, including hepatitis B and C, nonalcoholic steatohepatitis (NASH), and cirrhosis. These conditions can have serious health consequences and require careful monitoring and management. Cromos Pharma can help design and manage clinical trials to evaluate the safety and efficacy of new liver disease treatments, including antivirals, immunomodulators, and other therapies.

In addition, we have experience in conducting clinical trials for other digestive disorders, such as gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), and gastrointestinal cancers. Cromos Pharma can provide customized solutions to meet the specific needs of each study, whether it is a large multinational trial or a small, single-center study.

Our extensive knowledge of the regulatory and ethical issues involved in gastroenterology research and can help design and manage clinical trials to evaluate the safety and efficacy of new treatments. Cromos Pharma’s expertise in IBD, liver disease, and other digestive disorders makes it an essential partner for pharmaceutical and medical device companies looking to bring new products to market.

Our gastroenterologic experience includes:
    • Acute Bacterial Enteritis and Enterocolitis
    • Barrett’s esophagitis
    • Crohn’s Disease
    • Diarrhea
    • ESLD
    • GERD
    • Hepatitis B and C
    • IBS
    • Intestinal Colic
    • NASH
    • Pancreatic Insufficiency
    • Reflux Esophagitis
    • Ulcerative Colitis
Cromos Pharma Gastroenterology experience in the last five years
Clinical Sites
our Success story
A Phase III trial in Ulcerative Colitis for drug/device registration in the US
Click to openclose
Why Cromos Pharma
  • We are the only CRO to offer “No Patients, No Payment” risk sharing program, where the sponsor pays only if we deliver on our milestones.
  • We have the scientific and clinical expertise to support your clinical studies, from early to late phase, from single- to multi-country execution strategies.
  • By leveraging our international expertise, we deliver unparalleled results through diligent feasibility analysis, rapid startup, and accelerated recruitment, while utilizing proactive risk management strategies and maintaining the highest data quality.
  • Our team has vast expertise in organizing scientific advisory board meetings of key opinion leaders, clinicians, and industry stakeholders.



more therapeutics